580 results on '"Salloum, Fadi"'
Search Results
2. SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy
3. Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review
4. Higher diet quality relates to better cardiac function in cancer survivors: The multi-ethnic study of atherosclerosis
5. Physical Activity During Breast Cancer Therapy Associates With Preserved Exercise Capacity and Cardiac Function (WF97415)
6. Abstract 16049: Hydrogen Sulfide Attenuates Duchenne Cardiomyopathy via Suppression of Sterile Inflammation
7. Abstract 12321: Discordant Association of Nonalcoholic Fatty Liver Disease With Lipoprotein(a) and Markers of Atherogenic Dyslipidemia
8. NLRP3-mediated inflammation in cardio-oncology: sterile yet harmful
9. The inflammasome in cardiovascular diseases
10. Contributors
11. Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome
12. Cardiovascular Disease in Duchenne Muscular Dystrophy: Overview and Insight Into Novel Therapeutic Targets
13. Chronic treatment with serelaxin mitigates adverse remodeling in a murine model of ischemic heart failure and modulates bioactive sphingolipid signaling
14. Cardiac Gene Therapy With Relaxin Receptor 1 Overexpression Protects Against Acute Myocardial Infarction
15. Abstract 15439: Longitudinal Assessment of Racial Differences in Exercise Capacity After Breast Cancer Treatment: WF-97415
16. Abstract 15417: Dual Ampk Activator/mtor Inhibitor Improves Metabolic Parameters in T2d Mice and Protects Cardiomyocytes Against Ischemic Injury
17. Abstract 13531: Hydrogen Sulfide Donor, SG1002, Protects Against Hypertension-Induced Exacerbation of Doxorubicin Cardiotoxicity in Female Mice
18. Cardiac complications of cancer therapies
19. Hypertension Severity and Declines in Left Ventricular Ejection Fraction Among Women Receiving Adjuvant Chemotherapy for Breast Cancer (WF-97415 UPBEAT).
20. Immune Activation Mediates the Association of Advanced Hepatic Fibrosis With Adverse Outcomes in Patients With Coronary Artery Disease
21. Discordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemia
22. Remote Ischemic Pre-Conditioning Attenuates Adverse Cardiac Remodeling and Mortality Following Doxorubicin Administration in Mice
23. PDE5 inhibitor sildenafil attenuates cardiac microRNA 214 upregulation and pro-apoptotic signaling after chronic alcohol ingestion in mice
24. Independent roles of the priming and the triggering of the NLRP3 inflammasome in the heart
25. Sacubitril/Valsartan Averts Adverse Post-Infarction Ventricular Remodeling and Preserves Systolic Function in Rabbits
26. Reduced Thoracic Aortic Distensibility Upon Breast Cancer Diagnosis (WF-97415 and WF-98213)
27. Abstract P2185: Hydrogen Sulfide Donor Inhibits Cisplatin-induced Foam Cell Death In An In Vitro Model Of Atherosclerosis
28. Heart Disease and Relaxin: New Actions for an Old Hormone
29. Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213)
30. Abstract 17055: Novel Dual mTOR Inhibitor/AMPK Activator Mitigates Doxorubicin Cardiotoxicity and Potentiates Its Chemotherapeutic Efficacy Against Triple Negative Breast Cancer
31. Abstract 16878: Cardiac Overexpression of RXFP1 via AAV9 Gene Therapy Sensitizes Myocardial Inotropic Response to Serelaxin
32. Functional analysis of molecular and pharmacological modulators of mitochondrial fatty acid oxidation
33. Intermuscular Fat Changes Are Related to Reduced Left Ventricular Ejection Fraction During Cancer Therapy (PREVENT-WF-98213)
34. Priorities in Cardio-Oncology Basic and Translational Science:GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review
35. Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia–reperfusion in the mouse
36. Inflammasome Formation in Granulomas in Cardiac Sarcoidosis
37. Melanoma Treatment
38. Chronic treatment with novel nanoformulated micelles of rapamycin, Rapatar, protects diabetic heart against ischaemia/reperfusion injury
39. Abstract 24021: Sacubitril/Valsartan Attenuates Fibrosis and Improves Left Ventricular Function in a Rabbit Model of HFrEF
40. Abstract 16815: Novel Orally Active Hydrogen Sulfide-releasing Compound, SG1002, Attenuates QT Interval Prolongation and Improves LV Function and Survival in a Murine Model of Ischemic Cardiomyopathy
41. Abstract 16747: Targeted Deletion of Cardiac miR-17-92 Cluster Exacerbates Ischemic Myocardial Injury via PTEN Up-regulation
42. Abstract 16744: Cardiac Expression Profiles of Cofilin-2 and H2S-Producing Enzyme 3-Mercaptopyruvate Sulfurtransferase in Patients With End-Stage Ischemic Cardiomyopathy
43. Abstract 16515: Reperfusion Therapy With Sacubitril/Valsartan Attenuates Infarct Size and Preserves Left Ventricular Function in a Rabbit Model of Myocardial Infarction
44. Cardioprotective function of mitochondrial-targeted and transcriptionally inactive STAT3 against ischemia and reperfusion injury
45. Mitochondrial H 2 S Regulates BCAA Catabolism in Heart Failure
46. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism
47. Hydrogen sulfide mediates the cardioprotective effects of gene therapy with PKG-Iα
48. Remote ischemic preconditioning for myocardial protection: update on mechanisms and clinical relevance
49. Tadalafil Prevents Acute Heart Failure with Reduced Ejection Fraction in Mice
50. The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.